Abstract

During pregnancy, the occurrence of Sexually Transmitted Infections (STI) is a problem aggravated by the presence of the fetus, which presents difficulties in the use of certain drugs and the physiological adaptations of this phase in the pregnancypuerperal cycle. The World Health Organization (WHO) estimates that 448 million new STIs worldwide occur each year, of which the most frequent are associated with human papillomavirus (HPV), Chlamydia trachomatis, Neisseria gonorrhoeae.